In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • Dr. Eric Winer and Dr. Sara Tolaney led a study showing women with small stage 1, HER2-positive breast tumors, who received a combination of lower-intensity chemotherapy and a targeted drug following surgery, were unlikely to have the cancer recur within three years of treatment.


Tags: BreastCancer

  • Dana-Farber was mentioned as one of the institutions affiliated with Harvard that benefited from research dollars from the National Institute of Health.


Tags: BasicResearch

  • Dr. Robert J. Soiffer and Dr. Matthew S. Davids led a study showing the immune checkpoint blocker ipilimumab showed clinical benefit in nearly half of blood cancer patients who had relapsed following allogeneic stem cell transplantation.


Tags: StemCellTransplant

  • Dr. Christopher Sweeney discussed the future of prostate cancer research.

Tags: ProstateCancer

  • Dana-Farber was mentioned for its study, presented at the San Antonio Breast Cancer Symposium, that validated the myChoice HRD test to select the best chemotherapy for breast cancer patients before they have surgery.

Tags: BreastCancer

  • Dana-Farber/Boston Children's Cancer and Blood Disorders Center patient Carrick Wood went home for the first time on Christmas after spending the first six months of his life being treated for leukemia.


Tags: ChildhoodCancer

  • Sarah Reed, MPH, commented on the perceptions of how cancer patients and survivors should spend their holidays.


Tags: Nutrition

  • Lisa Scherber commented on the recent visit from Santa Claus to patients at Dana-Farber/Boston Children's Cancer and Blood Disorders Center.

Tags: ChildhoodCancer

  • Dr. Lisa Diller commented on the effects that childhood cancer treatment can have on adult survivors.

Tags: ChildhoodCancer

  • At the American Society of Hematology (ASH) annual meeting, Dr. Margaret Shipp and Dr. Philippe Armand presented their study finding 87 percent of Hodgkin lymphoma patients who participated in an early-phase immunotherapy clinical trial experienced cancer remission.


Tags: Lymphoma

Showing 31-40 of 514 items